![Vijay Karwal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vijay Karwal
Direttore/Membro del Consiglio presso
MEGA LIFESCIENCES
Profilo
Mr. Vijay Karwal is an Independent Non-Executive Director at OneSource Specialty Pharma Ltd., an Independent Director at Mega Lifesciences Public Co. Ltd. and a Chief Financial Officer at AffaMed Therapeutics (HK) Ltd. He is on the Board of Directors at OneSource Specialty Pharma Ltd. and Mega Lifesciences Public Co. Ltd.
Mr. Karwal was previously employed as a Managing Director by CBC Group (Singapore) Pte.
Ltd., an Operating Partner by Cbc Group Hk, a Managing Director by Nomura International (Hong Kong) Ltd., and a Chief Development Officer by Davita, Inc. (Singapore).
He received his graduate degree from the University of Groningen.
Posizioni attive di Vijay Karwal
| Società | Posizione | Inizio |
|---|---|---|
| MEGA LIFESCIENCES | Direttore/Membro del Consiglio | 13/05/2021 |
| ONESOURCE SPECIALTY PHARMA LIMITED | Direttore/Membro del Consiglio | 27/02/2025 |
AffaMed Therapeutics (HK) Ltd.
 AffaMed Therapeutics (HK) Ltd. BiotechnologyHealth Technology Develops and commercializes ophthalmology, neurological and psychiatric products | Direttore Finanziario/CFO | 01/05/2021 |
Precedenti posizioni note di Vijay Karwal
| Società | Posizione | Fine |
|---|---|---|
Cbc Group Hk
 Cbc Group Hk Investment ManagersFinance Functions as an alternative investment manager | Investitore di Private Equity | 01/04/2024 |
Nomura International (Hong Kong) Ltd.
 Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/05/2021 |
Davita, Inc. (Singapore) | Corporate Officer/Principal | 01/11/2017 |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Investitore di Private Equity | - |
Formazione di Vijay Karwal
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nomura International (Hong Kong) Ltd.
Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Mega Lifesciences Public Co. Ltd.
 Mega Lifesciences Public Co. Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and trades health food supplements & pharmaceutical products | Health Technology |
OneSource Specialty Pharma Ltd.
 OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics | Health Technology |
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Finance |
AffaMed Therapeutics (HK) Ltd.
AffaMed Therapeutics (HK) Ltd. BiotechnologyHealth Technology Develops and commercializes ophthalmology, neurological and psychiatric products | Health Technology |
Davita, Inc. (Singapore) | |
Cbc Group Hk
Cbc Group Hk Investment ManagersFinance Functions as an alternative investment manager | Finance |
